Cost of Medical Care for Chronic Kidney Disease and Comorbidity among Enrollees in a Large HMO Population

Journal of the American Society of Nephrology

Volumn 15, Issue 5, 2004, Pages 1300-1306

  Smith, David H ^a,b   Gullion, Christina M ^a   Nichols, Gregory ^a   Keith, Douglas Scott ^a,c   Brown, Jonathan Betz ^a  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; LABORATORY TEST; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; POPULATION RESEARCH; PRIORITY JOURNAL;

EID: 1942506578     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000125670.64996.BB     Document Type: Article

References (16)

1. Nissenson A, Pereira B, Collins A, Steinberg E: Prevalence and characteristics of individuals with chronic kidney disease in a large health maintenance organization. Am J Kidney Dis 37: 1177-1183, 2001
2. Chronic Kidney Disease Workgroup. Kidney disease outcomes quality initiative clinical practice guidelines. Am J Kidney Dis 39: S17-S31, 2002
3. US Renal Data System: USRDS 1999 Annual Data Report. Bethesda, MD, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, 1999
4. Brown JB, Pedula KL, Bakst AW: The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 159: 1873-1880, 1999
5. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Wagner EH: Patient-level estimates of the cost of complications in diabetes in a managed-care population. Pharmacoeconomics 16: 285-295, 1999
6. Combating chronic kidney disease: A managed care perspective. Am J Manag Care 8[Suppl 4]: S109-s136, 2002
7. Nissenson, AR, Collins, AJ, Hurley, J, Petersen, H, Pereira, BJG, and Steinberg, EP. Opportunities for improving the care of patients with chronic renal insufficiency: Current practice patterns. J Am Soc Nephrol 12: 1713-1720, 2001
8. Manjunath M, Sarnak M, Levey A: Prediction equations to estimate glomerular filtration rate: An update. Curr Opin Nephrol Hypertens 10: 785-792, 2001
9. Klag M, Whelton P, Randall B, Neaton J, Frederick L, Ford C et al: Blood pressure and end-stage renal disease in men. N Engl J Med 334: 13-18, 1996
10. Diabetes Control and Complications Trial Research Group. The effect of intensive treamtent of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
11. Nelson R, Bennett P, Beck G, Tan M, Knowler W, Mitch W, et al: Development and progression of renal disease in pima indians with non-insulin-dependent diabetes mellitus. N Engl J Med 335: 1636-1642, 1996
12. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352: 837-853, 1998
13. Hornbrook M, Goodman MJ. Adjusting health benefit contributions to reflect risks. In: Risk-Based Contributions to Private Health Insurance, edited by Hornbrook M, Greenwich, JAI Press Inc, 1991, pp 41
14. Lin D, Feuer E, Etzioni R, Wax Y: Estimating medical costs from incomplete follow-up data. Biometrics 53: 419-434, 1997
15. Khan S, Kazmi W, Abichandani R, Tighiouart H, Pereira B, Kausz A: Health care utilization among patients with chronic kidney disease. Kidney Int 62: 229-236, 2002
16. Centers for Medicare and Medicaid Services, Office of Information Services. Medicare Enrollees and Benefit Payments, by Area of Residence, Calendar Year 1999. Centers for Medicare and Medicaid Services, 2003. Available at: www.cms.hhs.gov/review/supp/2001/table73.pdf Accessed: 12-10-2003